EL7.AI
StocksMedium•17 November 2026•
4 min read

Infratil raises FY27 EBITDAF guidance to NZ$1,440 million

Key Facts

1Infratil raised FY27 relative operating EBITDAF guidance to NZ$1,370 million–NZ$1,440 million, from NZ$1,320 million–NZ$1,420 million at investor day.
2Relative operating EBITDAF in HY27 rose 28% to NZ$711 million, compared with NZ$555 million in HY26.
3CDC recorded EBITDAF of A$339 million in HY27, up 84%, with 350 megawatts deployed and 1.1 gigawatts of contracted capacity.
4Infratil raised FY27 relative capital expenditure guidance to NZ$4,150 million–NZ$4,450 million, from NZ$3,800 million–NZ$4,400 million.
5The company reported a net loss attributable to the parent company of NZ$248 million in HY27, compared with a NZ$606 million surplus in HY26.

Infratil raised its FY27 relative operating cash flow EBITDAF guidance to a range of NZ$1,370 million to NZ$1,440 million, according to its half-year results disclosure issued on November 18, 2026. The new range was above the estimate announced at the company’s investor day of NZ$1,320 million to NZ$1,420 million, as well as the May range of NZ$1,300 million to NZ$1,400 million. The results reported by the company cover HY27, the financial half-year ended September 30, 2026, and are not a forecast for the first half. Infratil said strong performance during the half and project delivery supported the updated full-year guidance. The higher range reflects operating contributions from several investments, led by CDC’s data centre business.

The company’s relative operating EBITDAF was NZ$711 million in HY27, up 28% from NZ$555 million in HY26. Infratil attributed the increase to growth at CDC, along with higher contributions from telecommunications company One New Zealand and renewable energy company Longroad Energy. Chief Executive Jason Boyes gave indicators of tangible expansion during the period, saying CDC added 90 megawatts of operating capacity, while Longroad added about 600 megawatts. He added that earnings momentum from construction programmes was accelerating as projects continued to be delivered. Both companies had additional capacity under construction during the half, linking the higher earnings guidance to asset expansion and delivery.

At CDC, EBITDAF rose to A$339 million in HY27, up 84% from the corresponding HY26 period. The company had 350 megawatts of data centre capacity deployed, while contracted capacity reached 1.1 gigawatts. CDC signed new contracts for 625 megawatts during the half and had 810 megawatts under construction on September 30. The company said full deployment of contracted capacity is expected to provide annual EBITDAF of A$2.2 billion. CDC also raised its FY27 guidance to a range of A$730 million to A$770 million, compared with the previous range of A$710 million to A$750 million, with annual EBITDAF expected to reach A$2.2 billion once contracted capacity is fully deployed by the end of FY29.

Capital expenditure expanded alongside business growth. Relative capital expenditure in HY27 rose 98% to NZ$2.1 billion, compared with NZ$1.1 billion in HY26. Infratil also raised its FY27 relative capital expenditure guidance range to NZ$4,150 million to NZ$4,450 million, from NZ$3,800 million to NZ$4,400 million. The asset portfolio’s value increased 8% to NZ$22.3 billion in HY27, compared with NZ$20.6 billion at the end of FY26. These figures show the expansion of the asset base and the investment required to support growth plans as the company raises its operating earnings guidance.

In contrast, Infratil reported a net loss attributable to the parent company of NZ$248 million in HY27, after a surplus of NZ$606 million in HY26. The company linked the loss to an accounting provision for incentive fees of NZ$256 million as of September 30, following the sharp increase in CDC’s valuation. It said the final value of any fees will remain linked to year-end valuations. This accounting item places the reported loss alongside the operating growth recorded during the half, without changing the fact that relative operating EBITDAF increased from the previous period. The company also confirmed a partially imputed interim distribution of 7.4 cents per share, payable on December 21, 2026.

In a project update, Infratil said the first building at CDC’s Laverton campus in Melbourne began operating in October, after reporting that construction and power delivery schedules were on track. According to Boyes, CDC had an additional 810 megawatts of data centre capacity under construction, alongside 2 gigawatts of contracted power capacity under construction. These projects indicate continued work to convert contracts and capacity under construction into operating assets. The disclosure also expects CDC to reach annual EBITDAF of A$2.2 billion once contracted capacity is fully deployed by the end of FY29. This comes as the company enters FY27 with higher guidance for both relative EBITDAF and capital expenditure.